Live Breaking News & Updates on Raciu

Stay updated with breaking news from Raciu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

AC Immune SA (NASDAQ:ACIU) Short Interest Update

AC Immune SA (NASDAQ:ACIU – Get Free Report) was the recipient of a large drop in short interest during the month of January. As of January 31st, there was short interest totalling 480,600 shares, a drop of 14.1% from the January 15th total of 559,300 shares. Based on an average daily trading volume, of 127,500 […] ....

China Universal Asset Management Co , Tower Research Capital , Balyasny Asset Management , Nixon Peabody Trust Co , Virtu Financial , Get Free Report , Universal Asset Management , Research Capital , Peabody Trust , Ac Immune , Nasdaq Aciu ,

AC Immune (NASDAQ:ACIU) Trading 13.8% Higher

Shares of AC Immune SA (NASDAQ:ACIU – Get Free Report) traded up 13.8% during trading on Monday . The company traded as high as $4.92 and last traded at $4.87. 277,917 shares were traded during trading, an increase of 51% from the average session volume of 184,616 shares. The stock had previously closed at $4.28. […] ....

Blackrock Inc , Balyasny Asset Management , Renaissance Technologies , Wells Fargo Company , Get Free Report , Asset Management , Wells Fargo , Ac Immune , Nasdaq Aciu ,

AC Immune (NASDAQ:ACIU) Shares Down 6.2%

AC Immune SA (NASDAQ:ACIU – Get Free Report) fell 6.2% during trading on Tuesday . The stock traded as low as $3.50 and last traded at $3.62. 99,878 shares were traded during mid-day trading, a decline of 70% from the average session volume of 336,394 shares. The stock had previously closed at $3.86. Analyst Ratings […] ....

Balyasny Asset Management , Ac Immune Company Profile , Virtu Financial , Dimensional Fund Advisors , Tower Research Capital , Get Free Report , Research Capital , Asset Management , Street Group , Ac Immune , Nasdaq Aciu ,

AC Immune (NASDAQ:ACIU) Upgraded by StockNews.com to "Hold"

StockNews.com upgraded shares of AC Immune (NASDAQ:ACIU – Free Report) from a sell rating to a hold rating in a research note issued to investors on Monday morning. Separately, HC Wainwright reissued a buy rating and set a $16.00 target price on shares of AC Immune in a research report on Monday. Get Our Latest […] ....

Platinum Investment Management Ltd , Wells Fargo Company , Citigroup Inc , Ac Immune Company Profile , Renaissance Technologies , Free Report , Investment Management , Avidity Partners Management , Partners Management , Get Free Report , Ac Immune , Nasdaq Aciu , Stocknews Com ,